Back
Sarepta Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
127.17
Seasonality Move:
0.19%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.97 | Buy |
| 20-day SMA: | 131.43 | Sell |
| 50-day SMA: | 137.6 | Sell |
| 200-day SMA: | 126.61 | Buy |
| 8-day EMA: | 126.89 | Buy |
| 20-day EMA: | 130.12 | Sell |
| 50-day EMA: | 134.31 | Sell |
| 200-day EMA: | 128.83 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.52 | Sell |
| Relative Strength Index (14 RSI): | 38.9 | Sell |
| Chaikin Money Flow: | 50230 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (126.71 - 139.27) | Sell |
| Bollinger Bands (100): | (124.42 - 147.62) | Sell |
Sarepta Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 127.17 while SRPT 8-day simple moving average is 125.97, which is a Buy signal.
- The stock price of SRPT is 127.17 while Sarepta Therapeutics 20-day SMA is 131.43, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 137.60 while SRPT share price is 127.17, making it a Sell technically.
- SRPT stock price is 127.17 and Sarepta Therapeutics 200-day simple moving average is 126.61, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $127.17. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
12.13B
Price in USD:
127.17
Share Volume:
710.4K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
55.25
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 127.17 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 127.17 while SRPT 8-day exponential moving average is 126.89, which is a Buy signal.
- The stock price of SRPT is 127.17 while Sarepta Therapeutics 20-day EMA is 130.12, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 134.31 while SRPT share price is 127.17, making it a Sell technically.
- SRPT stock price is 127.17 and Sarepta Therapeutics 200-day simple moving average is 128.83, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -3.52, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 38.9, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (126.71 - 139.27), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (124.42 - 147.62), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.